79383436 - JAQBO

Information

• Trademark
• 79383436

• Source

• Serial Number

  79383436

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations

• Filing Date

  September 14, 2023
  a year ago

• Transaction Date

  September 18, 2024
  a day ago

• Status Date

  September 03, 2024
  16 days ago

• Published for Opposition Date

  October 08, 2024
  18 days from now

• Location Date

  September 03, 2024
  16 days ago

• Status Code

  681

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  ABID, NABEELA

• Attorney Name

  John M. Kim

  Law Office Assigned Location Code

  O50

• Owners

  • JEIL PHARMACEUTICAL CO., LTD.

Case File Statements

• GS0051: Veterinary pharmaceutical preparations for the treatment of gastroesophageal reflux disease, peptic ulcer, intestinal disorders, gastrointestinal disorders, erosive esophagitis, gastritis, gastric ulcer, duodenal ulcer, non-erosive reflux disease, duodenal ulcer recurrence and pathological hypersecretory conditions, and Zollinger-Ellison syndrome, and combination antibiotic therapy being antibiotics for the treatment of Helicobacter pylori infection; pharmaceutical agents affecting digestive organs; medicines for treating intestinal disorders; proton-pump inhibitor, namely, medicines for the treatment of gastroesophageal reflux disease, peptic ulcer, intestinal disorders, gastrointestinal disorders, erosive esophagitis, gastritis, gastric ulcer, duodenal ulcer, non-erosive reflux disease, duodenal ulcer recurrence and pathological hypersecretory conditions, and Zollinger-Ellison syndrome, and combination antibiotic therapy being antibiotics for the treatment of Helicobacter pylori infection; medicines for the prevention and treatment of gastrointestinal diseases; medicines for the treatment of gastrointestinal diseases; medicines for human purposes, namely, medicinal preparations for the treatment of gastroesophageal reflux disease, peptic ulcer, intestinal disorders, gastrointestinal disorders, erosive esophagitis, gastritis, gastric ulcer, duodenal ulcer, non-erosive reflux disease, duodenal ulcer recurrence and pathological hypersecretory conditions, and Zollinger-Ellison syndrome, and combination antibiotic therapy being antibiotics for the treatment of Helicobacter pylori infection; pharmaceutical preparations for the treatment of gastroesophageal reflux disease, peptic ulcer, intestinal disorders, gastrointestinal disorders, erosive esophagitis, gastritis, gastric ulcer, duodenal ulcer, non-erosive reflux disease, duodenal ulcer recurrence and pathological hypersecretory conditions, and Zollinger-Ellison syndrome, and combination antibiotic therapy being antibiotics for the treatment of Helicobacter pylori infection; ethical medicinal preparations, namely, medicinal preparations for the treatment of gastroesophageal reflux disease, peptic ulcer, intestinal disorders, gastrointestinal disorders, erosive esophagitis, gastritis, gastric ulcer, duodenal ulcer, non-erosive reflux disease, duodenal ulcer recurrence and pathological hypersecretory conditions, and Zollinger-Ellison syndrome, and combination antibiotic therapy being antibiotics for the treatment of Helicobacter pylori infection

Case File Event Statements

• 5/9/2024 - 4 months ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 11/16/2023 - 10 months ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR

• 11/20/2023 - 10 months ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 11/24/2023 - 10 months ago

  3 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 5/9/2024 - 4 months ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 5/10/2024 - 4 months ago

  7 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS

• 5/10/2024 - 4 months ago

  6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 6/11/2024 - 3 months ago

  8 - REFUSAL PROCESSED BY IB Type: RFNT

• 7/30/2024 - a month ago

  10 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 7/30/2024 - a month ago

  11 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 7/30/2024 - a month ago

  9 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 9/3/2024 - 16 days ago

  13 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 9/3/2024 - 16 days ago

  12 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 9/3/2024 - 16 days ago

  15 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 9/3/2024 - 16 days ago

  16 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 9/3/2024 - 16 days ago

  14 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 9/18/2024 - a day ago

  17 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP